Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P-O Girodet

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Revue Des Maladies Respiratoires|May 2, 2008
[What is the therapeutic response to corticosteroid in smokers with asthma?]P-O Girodet
European Respiratory Review : an Official Journal of the European Respiratory Society|October 20, 2010
Epidemiology of COPDC Raherison, P-O Girodet
Revue Des Maladies Respiratoires|March 13, 2012
[Asthma exacerbations: pharmacological prevention]S Grassin-Delyle, P-O Girodet
Allergy|September 2, 2005
Mast cell myositis: a new feature of allergic asthma?P Berger, P-O Girodet, J Manuel Tunon-de-Lara
Journal of Enzyme Inhibition and Medicinal Chemistry|August 29, 2003
Synthesis and anti-histaminic evaluation of N-phenyl-(alkyl)-5-(dialkylamino)methyl-2-amino-2-oxazolinesJ J Bosc, F Pourageaud, P O Girodet, et al.
Fundamental & Clinical Pharmacology|April 7, 2005
Paradoxal effect of salbutamol in an in vitro model of bronchoprotectionP O Girodet, P Berger, B Martinez, et al.
Revue Des Maladies Respiratoires|October 27, 2005
[IgE and respiratory disease]P O Girodet, A Casset, A Magnan, et al.
Allergy|February 4, 2010
Mast cell adhesion to bronchial smooth muscle in asthma specifically depends on CD51 and CD44 variant 6P-O Girodet, A Ozier, T Trian, et al.
Respiratory Research|April 25, 2016
Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) studyP E Silkoff, M Laviolette, D Singh, et al.
Respiratory Research|November 19, 2015
Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling studyP E Silkoff, I Strambu, M Laviolette, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Revue Des Maladies Respiratoires|May 2, 2008
[What is the therapeutic response to corticosteroid in smokers with asthma?]P-O Girodet
European Respiratory Review : an Official Journal of the European Respiratory Society|October 20, 2010
Epidemiology of COPDC Raherison, P-O Girodet
Revue Des Maladies Respiratoires|March 13, 2012
[Asthma exacerbations: pharmacological prevention]S Grassin-Delyle, P-O Girodet
Allergy|September 2, 2005
Mast cell myositis: a new feature of allergic asthma?P Berger, P-O Girodet, J Manuel Tunon-de-Lara
Journal of Enzyme Inhibition and Medicinal Chemistry|August 29, 2003
Synthesis and anti-histaminic evaluation of N-phenyl-(alkyl)-5-(dialkylamino)methyl-2-amino-2-oxazolinesJ J Bosc, F Pourageaud, P O Girodet, et al.
Fundamental & Clinical Pharmacology|April 7, 2005
Paradoxal effect of salbutamol in an in vitro model of bronchoprotectionP O Girodet, P Berger, B Martinez, et al.
Revue Des Maladies Respiratoires|October 27, 2005
[IgE and respiratory disease]P O Girodet, A Casset, A Magnan, et al.
Allergy|February 4, 2010
Mast cell adhesion to bronchial smooth muscle in asthma specifically depends on CD51 and CD44 variant 6P-O Girodet, A Ozier, T Trian, et al.
Respiratory Research|April 25, 2016
Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) studyP E Silkoff, M Laviolette, D Singh, et al.
Respiratory Research|November 19, 2015
Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling studyP E Silkoff, I Strambu, M Laviolette, et al.
Pageof 1